Connect with us

/home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
">
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153

Warning: Attempt to read property "cat_name" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153

AM Best Affirms Credit Ratings of Fairfax Financial Holdings Limited and Majority of Its Subsidiaries

Published

on

Reading Time: 4 minutes

OLDWICK, N.J.–(BUSINESS WIRE)–AM Best has affirmed the Long-Term Issuer Credit Rating
(Long-Term ICR) of “bbb” and the various Long-Term Issue Credit Ratings
(Long-Term IR) on the unsecured debt and preferred equity of Fairfax
Financial Holdings Limited (Fairfax) (Toronto, Canada). AM Best
also has affirmed the Financial Strength Rating (FSR) of A (Excellent)
and the Long-Term ICRs of “a+” of the subsidiaries of Odyssey Group
Holdings, Inc. (Odyssey Group). The outlook of the Credit Ratings
(ratings) is stable. Additionally, AM Best has assigned the FSR of A
(Excellent) and the Long-Term ICR of “a+” to Newline Europe Versicherung
AG (Newline AG) (Germany), which has been rated as a member of and added
to the Odyssey Group. The outlook assigned to the ratings is stable.
Concurrently, AM Best has affirmed the FSR of A (Excellent) and the
Long-Term ICRs of “a” of the members of the Crum & Forster Insurance
Group (C&F), the members of the Zenith National Insurance Group (Zenith
Group), the members of Northbridge Financial Corporation (Northbridge)
(Toronto, Canada) and Wentworth Insurance Company Limited (Wentworth)
(Barbados). In addition, AM Best has affirmed the Long-Term ICRs of
“bbb” and the Long-Term IRs of Zenith National Insurance Corp.
(headquartered in Woodland Hills, CA) and Fairfax (US) Inc. (Delaware),
both of which are indirect wholly owned, downstream holding companies of
Fairfax. The outlook of these ratings is stable. (See link below for a
detailed listing of the companies and ratings.)

The ratings of Odyssey Group reflect its balance sheet strength, which
AM Best categorizes as strongest, as well as its strong operating
performance, neutral business profile and appropriate enterprise risk
management (ERM). The ratings also reflect group member Odyssey
Reinsurance Company’s (Odyssey Re) rank among the top global reinsurers,
supported by its diversified global geographic footprint, which includes
reinsurance and specialty primary insurance, large-line capacity and
broad product offerings. These positive attributes are supported by
Odyssey Re’s strongest risk-adjusted capitalization and strong operating
performance. Somewhat offsetting these strengths is Odyssey Re’s
challenging operating environment. The ratings assigned to Newline AG
reflect its strategic importance to the group, as it provides the
ability to continue servicing customers in the European Union
post-Brexit. It also reflects the explicit support afforded to that
entity via a net worth maintenance agreement and reinsurance agreement
with its parent, Newline Insurance Company Limited.

The ratings of C&F reflect its balance sheet strength, which AM Best
categorizes as very strong, as well as its adequate operating
performance, neutral business profile and appropriate ERM. The ratings
also reflect the benefits the group derives from its role within the
larger Fairfax enterprise. C&F also benefits from its diversified and
growing product portfolio and distribution networks. Management
continues to focus on growth in its specialty business at appropriate
rates, terms and conditions. Partially offsetting these positive rating
factors are the competitive market conditions that persist in the
commercial lines sector and relatively unfavorable expense levels.

The ratings of the Zenith Group reflect its balance sheet strength,
which AM Best categorizes as very strong, as well as its adequate
operating performance, neutral business profile and appropriate ERM. The
ratings also are enhanced by the benefits the group derives from its
position in the Fairfax enterprise. Furthermore, the ratings reflect
management’s expertise and commitment to maintaining underwriting
discipline throughout market cycles. Zenith’s underwriting performance
over many years has outperformed the workers compensation market.
Somewhat offsetting these positive rating factors is Zenith’s
concentration of written premium in California and Florida.

The ratings of Northbridge reflect the group’s balance sheet strength,
which AM Best categorizes as strongest, as well as its adequate
operating performance, neutral business profile and appropriate ERM. The
ratings of Northbridge also acknowledge the group’s position within
Canada’s commercial insurance market, diversified commercial lines
franchise and strong broker distribution network. The group continues to
benefit from improved and strong underwriting performance within its
small to mid-market commercial segment. Partially offsetting these
positive rating factors are competitive market conditions that persist
in Canada’s commercial and personal lines segments, and the group’s
relatively unfavorable expense levels.

The ratings of Wentworth reflect its balance sheet strength, which AM
Best categorizes as very strong, as well as its adequate operating
performance, limited business profile and appropriate ERM. The ratings
also are enhanced by the benefits it derives from its position in the
Fairfax enterprise. In addition, the ratings of Wentworth are supported
by its historically profitable underwriting performance and loss reserve
position. The company benefits from its investment portfolio, which
includes a significant allocation of cash and short-term securities.
Partially offsetting these positive rating factors are the company’s
limited business profile and a concentration of property catastrophe
exposures within its book of business, which subjects it to a
substantial degree of volatility as evidenced over the past few years.

A complete
listing
of Fairfax Financial Holdings Limited and its subsidiaries’
FSRs, Long-Term ICRs and Long-Term IRs also is available.

This press release relates to Credit Ratings that have been published
on AM Best’s website. For all rating information relating to the release
and pertinent disclosures, including details of the office responsible
for issuing each of the individual ratings referenced in this release,
please see AM Best’s
Recent
Rating Activity
web page. For additional information
regarding the use and limitations of Credit Rating opinions, please view
Understanding
Best’s Credit Ratings
. For information on the proper media
use of Best’s Credit Ratings and AM Best press releases, please view
Guide
for Media – Proper Use of Best’s Credit Ratings and AM Best Rating
Action Press Releases
.

AM Best is a global rating agency and information provider with a
unique focus on the insurance industry. Visit
www.ambest.com
for more information
.

Copyright © 2019 by A.M. Best Rating Services, Inc. and/or its
affiliates. ALL RIGHTS RESERVED.

Contacts

Jennifer Marshall, CPCU, ARM
Director
+1 908
439 2200, ext. 5327

[email protected]

Michael
Lagomarsino, CFA FRM

Senior Director
+1 908 439
2200, ext. 5810

[email protected]

Christopher
Sharkey

Manager, Public Relations
+1 908 439
2200, ext. 5159

[email protected]

Jim
Peavy

Director, Public Relations
+1 908 439
2200, ext. 5644

[email protected]


Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493

Warning: Attempt to read property "cat_ID" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493

Cannabis

Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect

Published

on

Continue Reading

Cannabis

Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand

Published

on

Continue Reading

transfer

IMC to transfer its Oranim Pharmacy shares back to the seller

Published

on

imc-to-transfer-its-oranim-pharmacy-shares-back-to-the-seller

TORONTO and GLIL YAM, Israel, April 16, 2024 /PRNewswire/ — IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the “Company” or “IMC“), a leading medical cannabis company with operations in Israel and Germany, is announcing that, further to the news release dated January 12, 2024, the Company has decided not to make remaining installment payments installments (i.e. NIS 5,873K including interest or 2,154K CAD) by IMC Holdings Ltd., and as such will transfer the 51% shares held by IMC Holdings Ltd back to the  seller.

“With the April 1st cannabis legalization in Germany, we are focusing our resources on the German market, where we expect to see the biggest growth potential,” said Oren Shuster, CEO of IMC. “With both of our core markets, Germany and Israel, currently undergoing rapid evolution, we need to assure that we allocate our resources to the growth opportunities where we expect the best return on investment.”

About IM Cannabis Corp.

IMC (Nasdaq: IMCC) (CSE: IMCC) is an international cannabis company that provides premium cannabis products to medical patients in Israel and Germany, two of the largest medical cannabis markets. The Company has recently exited operations in Canada to pivot its focus and resources to achieve sustainable and profitable growth in its highest value markets, Israel and Germany. The Company leverages a transnational ecosystem powered by a unique data-driven approach and a globally sourced product supply chain. With an unwavering commitment to responsible growth and compliance with the strictest regulatory environments, the Company strives to amplify its commercial and brand power to become a global high-quality cannabis player.

The IMC ecosystem operates in Israel through its commercial relationship with Focus Medical Herbs Ltd., which imports and distributes cannabis to medical patients, leveraging years of proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel that enable the safe delivery and quality control of IMC’s products throughout the entire value chain. In Germany, the IMC ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients. Until recently, the Company also actively operated in Canada through Trichome Financial Corp and its wholly owned subsidiaries, where it cultivated, processed, packaged, and sold premium and ultra-premium cannabis at its own facilities under the WAGNERS and Highland Grow brands for the adult-use market in Canada. The Company has exited operations in Canada and considers these operations discontinued.

Disclaimer for Forward-Looking Statements

This press release contains forward-looking information or forward-looking statements under applicable Canadian and U.S. securities laws (collectively, “forward-looking statements”). All information that addresses activities or developments that we expect to occur in the future are forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as “seek”, “anticipate”, “believe”, “plan”, “estimate”, “expect”, “likely” and “intend” and statements that an event or result “may”, “will”, “should”, “could” or “might” occur or be achieved and other similar expressions. Forward-looking statements are based on the estimates and opinions of management on the date the statements are made. In the press release, such forward-looking statements include, but are not limited to,  the occurrence of growth opportunities and the likelihood of growth potential.

Forward-looking statements are based on assumptions that may prove to be incorrect, including but not limited to: the development and introduction of new products; continuing demand for medical and adult-use recreational cannabis in the markets in which the Company operates; the Company’s ability to reach patients through both e-commerce and brick and mortar retail operations; the Company’s ability to maintain and renew or obtain required licenses; the effectiveness of its products for medical cannabis patients and recreational consumers; and the Company’s ability to market its brands and services successfully to its anticipated customers and medical cannabis patients.

The above lists of forward-looking statements and assumptions are not exhaustive. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated or implied by such forward looking statements due to a number of factors and risks. These include: any failure of the Company to maintain “de facto” control over Focus Medical in accordance with IFRS 10; the failure of the Company to comply with applicable regulatory requirements in a highly regulated industry; unexpected changes in governmental policies and regulations in the jurisdictions in which the Company operates; the effect of the reform on the Company; the Company’s ability to continue to meet the listing requirements of the Canadian Securities Exchange and the NASDAQ Capital Market; any unexpected failure to maintain in good standing or renew its licenses; the ability of the Company and Focus Medical (collectively, the “Group”) to deliver on their sales commitments or growth objectives; the reliance of the Group on third-party supply agreements to provide sufficient quantities of medical cannabis to fulfil the Group’s obligations; the Group’s possible exposure to liability, the perceived level of risk related thereto, and the anticipated results of any litigation or other similar disputes or legal proceedings involving the Group; the impact of increasing competition; any lack of merger and acquisition opportunities; adverse market conditions; the inherent uncertainty of production quantities, qualities and cost estimates and the potential for unexpected costs and expenses; risks of product liability and other safety-related liability from the usage of the Group’s cannabis products; supply chain constraints; reliance on key personnel; the risk of defaulting on existing debt and war, conflict and civil unrest in Eastern Europe and the Middle East

Any forward-looking statement included in this press release is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made.

The Company does not undertake any obligation to update forward-looking statements except as required by applicable securities laws. Investors should not place undue reliance on forward-looking statements. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement.

Company Contacts:

Anna Taranko, Director Investor & Public Relations
IM Cannabis Corp.
+49 157 80554338
[email protected]

Oren Shuster, Chief Executive Officer
IM Cannabis Corp.
[email protected]

Logo – https://mma.prnewswire.com/media/1742228/IM_Cannabis_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/imc-to-transfer-its-oranim-pharmacy-shares-back-to-the-seller-302117984.html

Continue Reading

Trending on Grassnews

GrassNews.net: Your premier portal for the latest developments in the cannabis industry. We provide timely news, insightful analysis, and in-depth features on everything from legislation changes and business trends, to scientific research and lifestyle topics. Stay informed and navigate the rapidly evolving cannabis landscape with GrassNews.net..

Contact us: [email protected]

Editorial / PR Submissions

Copyright © 2007 - 2024 Hipther Agency. Registered in Romania under Proshirt SRL, Company number: 2134306, EU VAT ID: RO21343605. Office address: Blvd. 1 Decembrie 1918 nr.5, Targu Mures, Romania